Patent ID: 9732061
Date: 2017-08-15
CPC Classifications: A61P,C07D

Claim:
1. A compound of formula (I) wherein R is selected from the group consisting of phenyl, furyl, thienyl, thiazolyl, benzothiazolyl and benzo[d][1,3]dioxolyl; wherein the phenyl, furyl, thienyl, thiazolyl, benzothiazolyl or benzo[d][1,3]dioxolyl is optionally substituted with one or more substituents independently selected from the group consisting of halogen, hydroxy, C is selected from the group consisting of phenyl, furyl, thienyl, thiazolyl, benzothiazolyl and benzo[d][1,3]dioxolyl; wherein the phenyl, furyl, thienyl, thiazolyl, benzothiazolyl or benzo[d][1,3]dioxolyl is optionally substituted with one or more substituents independently selected from the group consisting of halogen, hydroxy, C a is an integer from 0 to 1; L is selected from the group consisting of provided that when is selected from the group consisting of then a is 0 or a is 1 and L 1 is other than —N(R 2 ) and —N(R 2 )—CH 2 —; wherein R c is an integer from 0 to 2; each R wherein R wherein R wherein R E and R F are each independently selected from the group consisting of hydrogen, methyl and ethyl; b is an integer from 0 to 1; L provided that when is selected from the group consisting of then b is 0 or b is 1 and L 2 is other than —NH— or —N(CH 3 )—; is selected from the group consisting of phenyl, furan-2-yl, thien-2-yl; wherein the phenyl is optionally substituted with a substituent selected from the group consisting of halogen, hydroxy, cyano, C and wherein the furan-2-yl or thien-2-yl is optionally substituted with a substituent selected from the group consisting of halogen, C or a stereoisomer, tautomer or pharmaceutically acceptable salt thereof.